The effect of steroidal diosphenol agents on advanced breast cancer.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D003510:Cyclohexanes / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use / Q000652:urine; D005260:Female; D006062:Gonadotropins / Q000652:urine; D006065:Gonadotropins, Pituitary / Q000037:antagonists & inhibitors; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D008875:Middle Aged; D011388:Prolactin / Q000037:antagonists & inhibitors; D051381:Rats; D013448:Sulfobromophthalein; D013739:Testosterone / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D004967:Estrogens; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D013448:Sulfobromophthalein; D013739:Testosterone; D011388:Prolactin; D007770:L-Lactate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase